Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine Induction for CK/MK AML
NCT03080766Phase 2Unknown
- Sponsor
- The University of Hong Kong
- Start
- Mar 2017
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of decitabine in acute myeloid leukemia (AML), sponsored by The University of Hong Kong. Status: unknown.
02
Drugs
decitabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT03080766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03080766.